Cargando…
Prolonged Use of Oritavancin for Vancomycin-Resistant Enterococcus faecium Prosthetic Valve Endocarditis
Oritavancin is a novel lipoglycopeptide with activity against Gram-positive organisms including streptococci, methicillin-resistant Staphylococcus aureus, vancomycin-resistant S aureus (VRSA), and vancomycin-resistant enterococci (VRE) [1–3]. The US Food and Drug Administration approved oritavancin...
Autores principales: | Johnson, Jennifer A., Feeney, Eoin R., Kubiak, David W., Corey, G. Ralph |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4677157/ https://www.ncbi.nlm.nih.gov/pubmed/26677455 http://dx.doi.org/10.1093/ofid/ofv156 |
Ejemplares similares
-
In Vitro and In Vivo Studies of Oritavancin and Fosfomycin Synergism against Vancomycin-Resistant Enterococcus faecium
por: Lagatolla, Cristina, et al.
Publicado: (2022) -
Daptomycin-Vancomycin–Resistant Enterococcus faecium Native Valve Endocarditis: Successfully Treated With Off-Label Quinupristin-Dalfopristin
por: Hussain, Khandakar, et al.
Publicado: (2016) -
Genomics of vancomycin-resistant Enterococcus faecium
por: Gorrie, Claire, et al.
Publicado: (2019) -
1629. Vancomycin Resistance in Enterococcus faecium Clinical Isolates Responsible for Bloodstream Infections in US Hospitals Over Ten Years (2010-2019) and Activity of Oritavancin
por: Carvalhaes, Cecilia G, et al.
Publicado: (2020) -
Proof of concept for eradication of vancomycin resistant Enterococcus faecium from broiler farms
por: Nilsson, Oskar, et al.
Publicado: (2013)